SEC Company Response from BICYCLE THERAPEUTICS PLC (BCYC) (CIK 0001761612) (BCYC) — Jun 11, 2020
BICYCLE THERAPEUTICS PLC (BCYC) (CIK 0001761612)
Date: June 11, 2020 · CIK: 0001761612 · Accession: 0001104659-20-072426
AI Filing Summary & Sentiment
File numbers found in text: 333-238996
Show Raw Text
CORRESP 1 filename1.htm BICYCLE THERAPEUTICS PLC B900, Babraham Research Campus Cambridge CB22 3AT United Kingdom June 11, 2020 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Jeffrey Gabor RE: Bicycle Therapeutics plc Registration Statement on Form S-3 File No. 333-238996 Acceleration Request Requested Date: June 15, 2020 Requested Time: 4:00 p.m. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Exchange Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-238996) (the “Registration Statement”) to become effective at 4:00 p.m. Eastern Time on Monday, June 15, 2020, or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please orally confirm that event with Jaime L. Chase of Cooley LLP, counsel to the registrant, at (202) 728-7096. [Signature page follows] Sincerely, BICYCLE THERAPEUTICS PLC By: /s/ Lee Kalowski Lee Kalowski Chief Financial Officer and President cc: Kevin Lee, Chief Executive Officer, Bicycle Therapeutics plc Laura A. Berezin, Cooley LLP Ryan S. Sansom, Cooley LLP Jaime L. Chase, Cooley LLP